GNFT Genfit S.A.: Accounting Value per Share

Graphic logo of GENFIT (GNFT)

Genfit S.A. (GNFT) relies on patent protection for its hepatology developments, where massive R&D expenditures can lead to the creation of a highly profitable global monopolist. However, geopolitical fragmentation and trade restrictions are slowing down international trials and drug exports. This daily price action, where the metric is 0.00, is provided below for analytical convenience. Genfit S.A. (GNFT) maintains a high level of prestige among physicians and investors.

Genfit Corp (GNFT): Share Book Value from 07/04/2022 to 12/06/2025

Genfit SA - analytical breakdowns and key metrics (GNFT)

- price and consensus price forecast:
Stock Price Genfit Corp|GNFT - Forecast Levels Chart
- market capitalization data:
Market Valuation GENFIT|GNFT - Aggregate Business Value
- book capitalization data:
Net Assets per Single Share Genfit S.A.|GNFT - Net Asset Value|Market Capitalization to Book Value Ratio genfit.com|GNFT - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital Genfit S.A.|GNFT - Long-Term Debt to Capital|Short-Term Debt to Equity Genfit Corp|GNFT - Aggregate Debt Obligations|Debt to Book Capitalization Ratio GENFIT|GNFT - Company Long-Term Liabilities|Company Short-Term Debts Genfit S.A.
Fundamental company valuation:genfit.com - GNFT
Manufactured products of Genfit Corp

Licensing agreements with Ipsen and a steady flow of capital into the Genfit S.A. (GNFT) biotech ecosystem directly drive the dynamics reflected in the book value per share curve. This indicator is calculated as the difference between total assets and liabilities divided by the number of shares, allowing for an assessment of the business's actual resilience and the quality of its equity net of all debt.

Competitors of Genfit S.A. (GNFT)

Book Value per Share Arrowhead Pharmaceuticals Inc|Mirum Pharmaceuticals Inc (MIRM) - Share Book Value|DVAX - Accounting Value per Share|ABUS (arbutusbio.com) - Book Price of a Share|Net Assets per Single Share Inventiva IVA|Share Book Value Gyre Therapeutics Inc|Assembly Biosciences Inc (ASMB) - Book Value per Share|Accounting Value of a Share galectintherapeutics.com (GALT)|Book Value per Share DRRX (DURECT)|Aligos Therapeutics Inc. - Book Value per Share|Net Assets per Single Share BioVie Pharma (BIVI)|GLMD: Accounting Value of a Share|NDRA (ENDRA) - Net Assets per Single Share|Hepion Pharmaceuticals, Inc. (HEPA) - Accounting Value per Share